Jeffrey I. Weitz
Impact in
- Internal Medicine top 0.01%
- Venous Thromboembolism Diagnosis and Management
- Cardiology and Cardiovascular Medicine top 0.01%
- Atrial Fibrillation Management and Outcomes
- Antiplatelet Therapy and Cardiovascular Diseases
- Acute Myocardial Infarction Research
- Cardiac Arrhythmias and Treatments
Papers in
-
- Venous Thromboembolism Diagnosis and Management 264
- Hematology 185
- Blood Coagulation and Thrombosis Mechanisms 167
- Co-authors
- John W. EikelboomJack HirshJames C. FredenburghHarry R. BüllerAlan R. StaffordM SamamaGary E. RaskobJ. Hirsh
- Journals
- Thrombosis and Haemostasis (64 papers)Journal of Thrombosis and Haemostasis (44 papers)Blood (33 papers)Journal of Biological Chemistry (32 papers)Circulation (29 papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Jeffrey I. Weitz
516 papers receiving 40.4k citations
Hit Papers
Peers
Comparison fields: 5 of 179
- Internal Medicine 21.1k
- Cardiology and Cardiovascular Medicine 23.9k
- Hematology 9.2k
- Emergency Medical Services 2.2k
- Genetics 2.8k
Countries citing papers authored by Jeffrey I. Weitz
This map shows the geographic impact of Jeffrey I. Weitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey I. Weitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey I. Weitz more than expected).
Fields of papers citing papers by Jeffrey I. Weitz
This network shows the impact of papers produced by Jeffrey I. Weitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey I. Weitz. The network helps show where Jeffrey I. Weitz may publish in the future.
Co-authors
The 25 scholars most cited alongside Jeffrey I. Weitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 4 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 0 | |
| 7 | 2023 | 9 | |
| 8 | 2023 | 3 | |
| 9 | 2023 | 10 | |
| 10 | 2023 | 7 | |
| 11 | 2022 | 1 | |
| 12 | 2021 | 20 | |
| 13 | 2021 | 6 | |
| 14 | 2019 | 28 | |
| 15 | 2019 | 4 | |
| 16 | 2015 | 134 | |
| 17 | Initial results of the re-verse AD trial: idarucizumab reverses the anticoagulant effects of dabigatran in patients in an emergency setting of major bleeding, urgent surgery, or interventions | 2015 | 2 |
| 18 | 2011 | 84 | |
| 19 | 2003 | 31 | |
| 20 | 1978 | 4 |
About Jeffrey I. Weitz
Jeffrey I. Weitz is a scholar working on Internal Medicine, Hematology, Cardiology and Cardiovascular Medicine, Genetics and Cancer Research, having authored 528 papers that have together received 41.9k indexed citations. Recurring topics across this work include Venous Thromboembolism Diagnosis and Management (264 papers), Atrial Fibrillation Management and Outcomes (230 papers), Blood Coagulation and Thrombosis Mechanisms (167 papers), Antiplatelet Therapy and Cardiovascular Diseases (85 papers), Acute Myocardial Infarction Research (59 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (48 papers), Heparin-Induced Thrombocytopenia and Thrombosis (45 papers) and Blood properties and coagulation (44 papers). The work is most often cited by research in Internal Medicine (21.1k citations), Cardiology and Cardiovascular Medicine (23.9k citations), Hematology (9.2k citations), Emergency Medical Services (2.2k citations) and Genetics (2.8k citations). Jeffrey I. Weitz has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include John W. Eikelboom, Jack Hirsh, James C. Fredenburgh, Harry R. Büller, Alan R. Stafford, M Samama, Gary E. Raskob, J. Hirsh, Jeffrey S. Ginsberg and Giancarlo Agnelli. Their work appears in journals such as Thrombosis and Haemostasis, Journal of Thrombosis and Haemostasis, Blood, Journal of Biological Chemistry and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.